Associated Papers
Identification of High-Risk Single Nucleotide Polymorphisms in the Human CYB5R3 Gene Responsible for Recessive Congenital Methemoglobinemia: A Computational Approach.
Bouatrous E et al.
Molecular Syndromology, 2023
Neurological and Neuroimaging Features of CYB5R3-Related Recessive Hereditary Methemoglobinemia Type II.
Nicita F et al.
Brain Sciences, 2022
Mutation update: Variants of the CYB5R3 gene in recessive congenital methemoglobinemia.
Gupta V et al.
Human Mutation, 2020
Cellular and Molecular Mechanisms of Recessive Hereditary Methaemoglobinaemia Type II.
Siendones E et al.
Journal of Clinical Medicine, 2018
Congenital Methemoglobinemia Type II-Clinical Improvement with Short-Term Methylene Blue Treatment.
Cooper MS et al.
Pediatric Blood & Cancer, 2016
Primaquine-induced severe methemoglobinemia developed during treatment of Plasmodium vivax malarial infection in an Indian family associated with a novel mutation (p.Agr57Trp) in the CYB5R3 gene.
Kedar P et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2014
Methemoglobin reductase deficiency: novel mutation is associated with a disease phenotype of intermediate severity.
Percy MJ et al.
Journal of Pediatric Hematology/oncology, 2012
Select a paper to view details